Professor Andrew J Pollard
Professor Andrew J Pollard
Verified email at
Cited by
Cited by
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ...
The Lancet 396 (10249), 467-478, 2020
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines
AJ Pollard, KP Perrett, PC Beverley
Nature Reviews Immunology 9 (3), 213-220, 2009
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization …
N Gossger, MD Snape, LM Yu, A Finn, G Bona, S Esposito, N Principi, ...
Jama 307 (6), 573-582, 2012
A CD8+ T cell transcription signature predicts prognosis in autoimmune disease
EF McKinney, PA Lyons, EJ Carr, JL Hollis, DRW Jayne, LC Willcocks, ...
Nature medicine 16 (5), 586, 2010
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles …
J Findlow, R Borrow, MD Snape, T Dawson, A Holland, TM John, A Evans, ...
Clinical Infectious Diseases 51 (10), 1127-1137, 2010
Meningococcal disease: clinical presentation and sequelae
D Pace, AJ Pollard
Vaccine 30, B3-B9, 2012
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ...
The Lancet 396 (10267), 1979-1993, 2020
Haemophilus influenzae type b conjugate vaccines
DF Kelly, ER Moxon, AJ Pollard
Immunology 113 (2), 163-174, 2004
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial
MD Snape, KP Perrett, KJ Ford, TM John, D Pace, LM Yu, JM Langley, ...
Jama 299 (2), 173-184, 2008
Emergency management of meningococcal disease
AJ Pollard, J Britto, S Nadel, C DeMunter, P Habibi, M Levin
Archives of disease in childhood 80 (3), 290-296, 1999
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
RC Read, D Baxter, DR Chadwick, SN Faust, A Finn, SB Gordon, ...
The Lancet 384 (9960), 2123-2131, 2014
Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells
EA Clutterbuck, R Lazarus, LM Yu, J Bowman, EAL Bateman, L Diggle, ...
Journal of Infectious Diseases 205 (9), 1408-1416, 2012
Safety and immunogenicity of novel adenovirus type 26–and modified vaccinia ankara–vectored ebola vaccines: a randomized clinical trial
ID Milligan, MM Gibani, R Sewell, EA Clutterbuck, D Campbell, E Plested, ...
Jama 315 (15), 1610-1623, 2016
A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA
K Ewer, T Rampling, N Venkatraman, G Bowyer, D Wright, T Lambe, ...
New England Journal of Medicine 374 (17), 1635-1646, 2016
Meningococcal polysaccharide–protein conjugate vaccines
MD Snape, AJ Pollard
The Lancet infectious diseases 5 (1), 21-30, 2005
Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial
MD Snape, T Dawson, P Oster, A Evans, TM John, B Ohene-Kena, ...
The Pediatric infectious disease journal 29 (11), e71-e79, 2010
Vaccine prevention of meningococcal disease, coming soon?
SL Morley, AJ Pollard
Vaccine 20 (5-6), 666-687, 2001
Global epidemiology of meningococcal disease and vaccine efficacy
AJ Pollard
The Pediatric infectious disease journal 23 (12), S274-S279, 2004
Development of natural immunity to Neisseria meningitidis
AJ Pollard, C Frasch
Vaccine 19 (11-12), 1327-1346, 2001
The system can't perform the operation now. Try again later.
Articles 1–20